Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Curr Opin Otolaryngol Head Neck Surg. 2015 Apr;23(2):107–114. doi: 10.1097/MOO.0000000000000138

Table 3.

Incidence of nodal disease at presentation and after treatment2,3,5,7-9,12,13,14,21,24-27.

Study Overall % with nodes at presentation SCC% with nodes at presentation Treatment of N0 neck Overall N0 patients with nodal failure SCC N0 patients with nodal failure
Hinerman 20112! -- -- None -- 2/22 (9%)
-- -- ENI unilat
ENI bilat
-- 1/14 (4%)#
0/9
Le 20003@ 11/97 (11.3%) 9/58 (15.5%) None 10/97 (10.3%) 20%
-- -- ENI 0/25 (0%) --
Valentino 20105@ 2/17 (11.7%) 1/7 (14.3%) none -- --
Paulino 19977! -- 4/42 (9.5%) None -- 11/38 (28.9%)
Homma 20148# -- 28/128 (21.9%) none -- 8/83 (9.6%)
Yagi 20019@ 9/118 (7.9%) -- None 9/109 (8.3%) --
Cantu 200812@ 33/399 (8.3%) 16/156 (10.3%) None 51/399 (12.5) --
Kim 199913! -- 12/116 (10.3%) None 14/104 (13.5%) 14/104 (13.5%)
Mirghani 201314$ 8/155 (5.2%) None 16/133 (12.0%)
Jaing 199121@ 6/73 (8.2%) -- none 11/50 --
-- -- ENI 0/17 --
Dulguerov 200124@ 3/103 (2.9%) -- none (4%) --
SEER 1988-199825@ 45/601 (7.5%) -- -- -- --
Giri 199126@ 3/41 (7.5%) -- -- 3/35 (8%)
Syners 200927$ 18/168 (11%) 10/55 (18%) 11% 11%

ENI, elective neck irradiation

!

SCC of maxillary sinus

@

includes all malignant histologies originating in the maxillary sinus

#

T4 SCC lesions of maxillary sinus

$

includes all histologies and subsites in paranasal sinuses